The use of colonoscopy as a primary screening test for colorectal cancer (CRC) in average risk adults is a subject of controversy. Our primary objective was to build a predictive model based on a few simple variables that could be used as a guide for identifying average risk adults more suitable for examination with colonoscopy as a primary screening test.
INTRODUCTION
Colorectal cancer (CRC) is the second most frequent cause of cancer-related death in western countries (1) . Most cancers develop from benign adenomatous polyps (2, 3) , in subjects with no known risk factors for the disease (4) . Although it is not yet possible to determine which adenomas will progress to cancer, certain pathological features have been found to correlate with the risk of progressing to CRC (3, 5) . "Advanced adenomas" have been defined as those with at least one of the following characteristics: size 1 cm or larger, tubulovillous or villous histology, and moderate or severe dysplasia (6 -9) .
Screening with full colonoscopy as a primary procedure has been limited to a few small series (10 -16) , and results have not been focused in advanced adenomas. Two large colonoscopic series recently published (17, 18) have assessed the proportion of advanced proximal adenomas in average risk adults. Although the prevalence of colonic adenomas is higher among men than among women (5, 12, 19, 20) and increases with age (11, 13, 15) , more data are needed to adequately assess the independent role of the most relevant predictors of advanced adenomas (18) . A variety of factors have been linked to the development of adenomas or CRC (21) (22) (23) (24) (25) , but currently there is no dominant risk factor that could be practically used for risk stratification in screening for neoplasia among average risk adults without known family history of CRC. Abdominal symptoms with no evidence of bleeding have been considered a poor indication for colonoscopy in series with small numbers of patients (26 -29) . Clarification of the relative impact of these and other variables on the risk of advanced adenomas in average risk persons is needed, because such clarification might provide basis to design more efficient CRC screening strategies.
We performed total colonoscopy in a large series of average risk subjects without any symptoms suggesting colonic neoplasm, to establish the prevalence of advanced adenomas and to analyze which clinical and biochemical data could predict their presence in these patients. Our primary objective was to build a predictive model based on a few simple variables which, having significant associations with the presence of advanced neoplasms, could at the same time be easily obtained for each patient. This model could be used as a guide for identifying adults more suitable for examination with colonoscopy as a primary screening test.
MATERIALS AND METHODS

Study Design
From 1988 to 1998, full colonoscopy was performed as a primary screening procedure in all consecutive patients 40 yr of age or older, without family history of CRC or any symptom suggesting colonic neoplasm, who were referred to our endoscopy unit for CRC screening. The study protocol was approved by a central human-rights committee, and written informed consent was obtained in all cases.
Patients were recruited in one of two ways: 1) if they came for a routine health check-up, or 2) if they were attending medical clinics for follow-up of stable medical problems. All the patients provided a routine medical history and underwent physical examination before the colonoscopy. Clinical and biochemical data were recorded as shown in Table 1 . Body mass index (BMI: weight in kilograms/squared height in meters) was used to measure body fat.
Any subject who underwent colonoscopy but had reported hematochezia, a change in bowel habit, development of persistent abdominal or rectal pain (in the year before colonoscopy) was excluded. Other exclusion criteria were iron deficiency anemia, weight loss, previous colon polyps or cancer, any first degree relative(s) with colon cancer, previous breast or uterine cancer, inflammatory bowel disease, previous abdominal radiation, colonoscopy or barium enema within 5 yr performed for any indication, and use of anticoagulants. Subjects who had an incomplete colonoscopy were excluded from the analysis. Fecal occult blood testing was not performed before colonoscopic screening.
Patients were prepared for colonoscopy by administration of PEG-electrolyte GI lavage or oral phosphosoda. Colonoscopies were performed by staff gastroenterologists or gastroenterology fellows under the supervision of a staff gastroenterologist, with the Olympus CF-V10L, CF-100HL, CF-130L, or CFQ-140L (Olympus Europa, Barcelona, Spain) colonoscopes. Meperidine plus midazolam or propofol were used as needed for sedation. All polyps were removed with standard polypectomy snares.
The following endoscopic findings were assessed: 1) location of each colorectal neoplasm (cancer or polyp) according to the distance from the anal verge, as measured with markings on the endoscope, and 2) size of each polyp (when seen intact or first removed).
Standard methods were used for histologic assessment, with all polyps fixed in 10% formol saline, totally embedded, and routinely stained with hematoxylin and eosin (30, 31) , and were diagnosed according to the criteria of the World Health Organization by pathologists with a special expertise in GI pathology. Dysplasia was graded as mild, moderate, or severe (32) . Patients with intramucosal carcinoma or carcinoma in situ were classified as having severe dysplasia (30) . CRC was defined as the invasion of malignant cells beyond the muscularis mucosa.
Patients with multiple adenomas were categorized according to the largest tumor diameter, the most villous histology, and the most severe grade of dysplasia.
To make our data comparable with other studies (6 -9, 15, 17), we considered two definitions of "advanced adenoma": 1) "broad definition," if any of the following criteria were fulfilled for any adenoma: size 1 cm or larger, villous (or tubulovillous) histology, and moderate or severe grade of dysplasia; and 2) "restricted definition" in which moderate dysplasia was excluded (i.e., only severe dysplasia was considered).
Statistical Analysis
We compared clinical and biochemical data of patients with no adenomas, patients with nonadvanced adenomas, and patients with at least one advanced colonic adenoma. Chisquared test for linear trend and one-way analysis of variance were used for between-group comparisons. A p value of less than 0.05 was considered statistically significant.
Multiple logistic regression was used to identify independent predictors of advanced adenomas. Two different logistic regression models were constructed, depending on the 
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Colonoscopy for Primary Screening of CRC criteria for advanced lesion ("broad" or "restricted" criteria, see above) used as the dependent variable. The independent variables were selected according to the purposeful method (33) . Initial candidate variables were those with p Ͻ 0.25 in the univariate analysis. We examined whether there was any significant interaction (effect modification) between every two independent variables included in multivariate analysis.
A receiver operating characteristic (ROC) plot was constructed, and the area under the curve was estimated to assess the degree of discrimination provided by the model (34) .
To predict the presence of advanced neoplasms in a given individual, a diagnostic score was designed with the independent variables selected by the multivariate analysis. Continuous variables were converted into categoric variables. A new logistic regression model was run with these transformed variables. The coefficients yielded by the model were rounded to the nearest half integer and then multiplied by 2 to avoid decimals. A score for each subject was computed. The validity of the score was assessed by ROC analysis.
RESULTS
Characteristics of Patients With and Without Advanced Adenomas
From 1988 to 1998, 2260 consecutive average risk persons underwent primary colonoscopic screening. Colonoscopy was completed to cecum in 2210 patients (97.8%), who were included in our analysis. Characteristics of the study population are shown in Table 1 . Their mean age was 57.9 yr (SD ϭ 8.6); 74.6% were men.
Patients were classified on the basis of the most advanced lesion (Table 2) . No polypoid lesions were found in 1385 patients (62.7%). Among the other 825 (37.3%), 2210 polyps were removed. Six hundred seventeen patients (27.9%) had adenomas of any type or invasive cancer. Advanced disease (defined as an adenoma 10 mm or larger, or with villous features, moderate-to-severe dysplasia, or invasive cancer) was present in 259 patients (11.7%). In 54 (2.4%) the most advanced lesion were tubular adenomas 10 mm or larger. Ninety patients (4.0%) had adenomas with villous features, 153 (6.9%) had adenomas with moderate dysplasia, and 27 (1.2%) had adenomas with severe dysplasia or invasive cancer. Among the 11 patients with invasive cancer (mean age 66.6 yr; 10 male), the stage was T1N0 in four, T2N0 in two, and T3N0 in three; two patients had nodal involvement, and none had metastatic disease. Five patients had cancers proximal to the splenic flexure.
When moderate dysplasia was accepted as a criterion for "advanced lesion" (Table 3) , 68 patients (26.3%) had advanced lesions only in the proximal colon, 137 (52.9%) had advanced disease only in the distal colon (i.e., distal to the splenic flexure), and 54 (20.8%) had advanced neoplasms in both the distal and the proximal colon.
When the "restricted" definition for advanced adenoma was applied (Table 3) , 37 patients (23.7%) had advanced lesions only in the proximal colon, 100 had advanced disease only in the distal colon (64.1%), and 19 (12.2%) presented advanced neoplasms in both colonic segments.
Comparisons of clinical and biochemical data of patients according to the existence and severity colonic adenomas are shown in Table 4 . Nonadvanced adenomas were found in 18.4% of men but only in 9.8% of women. Advanced adenomas were also more likely to be present in men than in women (13.5% vs 6.6%). Persons with adenomas were significantly older than those without adenomas (59.8 vs 57.2 yr), and patients with advanced lesions were significantly older than those with nonadvanced neoplasms. Adenomas were associated with a significantly higher mean BMI (27.4 vs 26.9 kg/m 2 ). Patients with advanced lesions also had a significantly higher BMI than those with nonadvanced adenomas. Mean cholesterol levels were significantly higher among persons with adenomas than among those without adenomas (234.8 vs 228.3 mg/dl), but no significant differences were found in nonadvanced versus advanced lesions.
There were no differences in the rates of adenomas according to the form of recruitment, the presence of nonspecific GI symptoms, bowel habit, daily consumption of nonsteroidal anti-inflammatory drugs, or triglycerides serum levels.
Similar results were found when we considered the "restricted" criteria for advanced adenoma (data not shown).
Analysis of Predictive Factors Associated With Advanced Adenomas in Average Risk Persons
In univariate analysis, older age, male sex, and higher BMI were significantly associated with a higher probability of advanced adenoma. In the multivariate logistic regression model, age, sex, and BMI were shown to be significantly and independently associated with advanced lesions (Table  5 ). The prevalence of advanced adenomas increased monotonically with age. When age was introduced as a continuous variable, the adjusted OR was 1.05 (95% CI ϭ 1.03-1.07) for both definitions of advanced adenomas (data not shown). Male sex was associated with a significantly higher risk of advanced adenomas after adjusting for the other variables in the model (OR ϭ 2.08 for the broad definition and OR ϭ 3.64 for the restricted definition). The risk of advanced adenomas significantly increased with a higher BMI (adjusted OR for BMI Ͼ 30 kg/m 2 ϭ 2.08 for the broad definition and 1.78 for the restricted definition). The adjusted ORs for BMI as a continuous variable were 1.06 and 1.04 (broad and restricted definitions, respectively).
We also examined the interaction between every two independent variables included in the multivariate analyses. None of them showed statistical significance.
A score was designed as follows. Gender, BMI, and age (the latter two as continuous variables) were selected by a stepwise procedure. BMI and age were converted into cat- 
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Colonoscopy for Primary Screening of CRC egoric variables. BMI was grouped in 10-point categories (Յ25, 26 -35, and Ͼ35 kg/m 2 ). Age was grouped into decades. A new logistic regression model was run with these transformed variables. The coefficients yielded by the model were rounded to the nearest half integer (0.8 was rounded to 1 and 0.6 to 0.5) and then multiplied by 2 to avoid decimals. The coefficients in the model were 0.76, 0.46, and 0.41 for sex, BMI, and age, respectively. Therefore, to be male received 2 points (female ϭ 0); each 10 kg/m 2 above 25 in BMI received 1 point, and the same was applied for each decade above 50 yr ( Table 6 ).
The validity of the score was assessed by ROC analysis. The areas under the ROC curve with the logistic models including the original variables were 65.37% and 67.24% for both the broad and the restricted criteria used to define advanced adenoma, respectively. The loss of validity with the transformed variables was negligible (approximately 1%).
With higher score, the number of persons who should undergo colonoscopic screening to detect at least one advanced lesion progressively decreased, as shown in Table 7 .
DISCUSSION
We found that age, gender, and BMI are independent predictors of the risk of advanced adenoma in average risk adults, although their predictive value is low. Nevertheless, in the absence of better predictors, these variables, which can be easily obtained, might help in the selection of more suitable candidates for primary screening colonoscopy.
Most small simple tubular adenomas do not progress to cancer (35) . However, adenomas with advanced features Few studies have evaluated variables associated with the presence of advanced colonic adenomas in average risk, asymptomatic adults, and limited clinical information is available to supplement the findings provided by the screening examinations. Advanced disease was present in 11.7% in our series (7.0% if we considered the restricted definition for advanced adenoma), a percentage similar to that found in a recent large series in the United States (17) . To better establish the yield of colonoscopy as a primary screening procedure, fecal occult blood testing was not performed before endoscopic examination. We carefully screened the subjects included in our analysis to ensure that they have neither family history of CRC nor any symptom suggesting high risk status. In fact, the prevalence of polyps was unrelated to several other clinical variables included in the analyses. Patients with nonspecific abdominal symptoms had similar rates of advanced adenomas as asymptomatic patients (10.9% vs 12.2%, p ϭ 0.34), as reported in some small studies and a recent large series (26 -29, 37, 38) , and there were no differences according to the method used to recruit patients (p ϭ 0.88). Altered bowel habit was not a predictor of advanced adenoma in our series. Therefore, the prevalence of significant lesions in this population largely reflects the background prevalence in asymptomatic populations.
Information on the prevalence of advanced adenomas by age and gender is limited; one autopsy series reported a prevalence of large polyps of 4.6% at age greater than 54 yr and 15.6% at 75 yr (39). Rex et al. (13) reported that 15% of asymptomatic men and 7% of women aged 60 yr or older had advanced colorectal neoplasms. Similar percentages had been found in small clinical series and autopsy studies (11, 12, 14, 40 -42) . We found a linear association between age and the prevalence of advanced colonic neoplasia. The higher yield of screening colonoscopy in men is consistent with recent reports that CRC incidence and mortality are now approximately 1.6-fold greater in men than in women (43) .
In our series, BMI at screening colonoscopy was an independent predictor of advanced adenomas. Studies of obesity and colorectal polyps have presented somewhat conflicting findings (22, 24, 44 -47) . Approximately half of them show a positive association between BMI or some other anthropometric measures and large-bowel polyps (24, 44, 45) . In a recent study, current BMI, the net amount of weight gained during the 10 yr before sigmoidoscopy, and the number of large weight changes during adulthood were independently associated with colorectal adenomas (48) . To our knowledge, this is the first report that analyzes BMI as an independent risk factor for advanced adenomas in a large population undergoing primary colonoscopic screening. Obesity might be a marker for one or more risk factors for CRC. Body weight is largely a function of the net effects of energy expenditure and energy intake. Given the difficulty of measuring both physical activity and dietary intake accurately, BMI could represent a more practical method of determining the cumulative effects of these two variables.
A limitation of this study should be emphasized: our sample was biased toward persons with medium-to-high socioeconomic status, interested in undergoing CRC screening. However, none of these factors is acknowledged as a major determinant of the incidence of colorectal neoplasms.
Our data might provide guidance regarding population strategies for CRC screening, as well as ground for discussing relative risks with individual patients in clinical settings. Population screening colonoscopy for certain subgroups of average risk persons, such as men (particularly obese) older than 60 yr, would produce a substantial yield of lesions at increased risk for the subsequent development of CRC.
